Necrotizing Fasciitis Caused by Community-Associated Methicillin-Resistant Staphylococcus aureus in Los Angeles
Open accessThe DOI matches its Crossref record; 60 of the 62 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Necrotizing fasciitis is a life-threatening infection requiring urgent surgical and medical therapy. Staphylococcus aureus has been a very uncommon cause of necrotizing fasciitis, but we have recently noted an alarming number of these infections caused by community-associated methicillin-resistant S. aureus (MRSA). METHODS: We reviewed the records of 843 patients whose wound cultures grew MRSA at our center from January 15, 2003, to April 15, 2004. Among this cohort, 14 were identified as patients presenting from the community with clinical and intraoperative findings of necrotizing fasciitis, necrotizing myositis, or both. RESULTS: The median age of the patients was 46 years (range, 28 to 68), and 71 percent were men. Coexisting conditions or risk factors included current or past injection-drug use (43 percent); previous MRSA infection, diabetes, and chronic hepatitis C (21 percent each); and cancer and human immunodeficiency virus infection or the acquired immunodeficiency syndrome (7 percent each). Four patients (29 percent) had no serious coexisting conditions or risk factors. All patients received combined medical and surgical therapy, and none died, but they had serious complications, including the need for reconstructive surgery and prolonged stay in the intensive care unit. Wound cultures were monomicrobial for MRSA in 86 percent, and 40 percent of patients (4 of 10) for whom blood cultures were obtained had positive results. All MRSA isolates were susceptible in vitro to clindamycin, trimethoprim-sulfamethoxazole, and rifampin. All recovered isolates belonged to the same genotype (multilocus sequence type ST8, pulsed-field type USA300, and staphylococcal cassette chromosome mec type IV [SCCmecIV]) and carried the Panton-Valentine leukocidin (pvl), lukD, and lukE genes, but no other toxin genes were detected. CONCLUSIONS: Necrotizing fasciitis caused by community-associated MRSA is an emerging clinical entity. In areas in which community-associated MRSA infection is endemic, empirical treatment of suspected necrotizing fasciitis should include antibiotics predictably active against this pathogen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H., & Swaminathan, B. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.9.2233-2239.1995 · Cited by 8,204
Enright, M. C., Day, N. P. J., Davies, C. E., Peacock, S. J., & Spratt, B. G. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.3.1008-1015.2000 · Cited by 3,063
Lina, G., Piemont, Y., Godail-Gamot, F., Bes, M., Peter, M.-O., Gauduchon, V., Vandenesch, F., & Etienne, J. (1999) · Clinical Infectious Diseases · doi:10.1086/313461 · Cited by 2,489
Vandenesch, F., Naimi, T., Enright, M. C., Lina, G., Nimmo, G. R., Heffernan, H., Liassine, N., Bes, M., Greenland, T., Reverdy, M.-E., et al. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0908.030089 · Cited by 1,727
Naimi, T. S. (2003) · JAMA · doi:10.1001/jama.290.22.2976 · Cited by 1,688
Gillet, Y., Issartel, B., Vanhems, P., Fournet, J.-C., Lina, G., Bes, M., Vandenesch, F., Piémont, Y., Brousse, N., Floret, D., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07877-7 · Cited by 1,514
The Changing Epidemiology of Staphylococcus aureus?
Chambers, H. F. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0702.010204 · Cited by 1,495
McDougal, L. K., Steward, C. D., Killgore, G. E., Chaitram, J. M., McAllister, S. K., & Tenover, F. C. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.11.5113-5120.2003 · Cited by 1,399
Diekema, D. J., Pfaller, M. A., Schmitz, F. J., Smayevsky, J., Bell, J., Jones, R. N., Beach, M., & SENTRY Participants Group (2001) · Clinical Infectious Diseases · doi:10.1086/320184 · Cited by 1,362
Oliveira, D. C., & Lencastre, H. D. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2155-2161.2002 · Cited by 1,343
Research works printed but not linked: 6
- 2003, MMWR Morb Mortal Wkly Rep, 52, 88
- Headley AJ, 2003, Am Fam Physician, 68, 323
- Wu KC, 2002, J Microbiol Immunol Infect, 35, 53
- 2003, MMWR Morb Mortal Wkly Rep, 52, 793
- Perdreau-Remington F, Pan E, Carleton H, Diep B, Harvey S, Sensabaugh G. Staphylococcus aureus infections in Northern and Southern California jails in 2002 due to a single clone carrying Panton-Valentine leukocidin. In: Program and abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, September 14–17, 2003. Washington, D.C.: American Society for Microbiology, 2003:382. abstract.
- 2003, MMWR Morb Mortal Wkly Rep, 52, 992
Cited by
Items 201–300 of 1,000
Rehm, S. J., & Tice, A. D. (2010) · Clinical Infectious Diseases · doi:10.1086/653518 · Cited by 85
Olaniyi, R., Pozzi, C., Grimaldi, L., & Bagnoli, F. (2016) · Current topics in microbiology and immunology · doi:10.1007/82_2016_32 · Cited by 94
Elie-Turenne, M.-C., Fernandes, H., Mediavilla, J. R., Rosenthal, M. E., Mathema, B., Singh, A., Cohen, T. R., Pawar, K. A., Shahidi, H., Kreiswirth, B. N., et al. (2010) · Infection Control and Hospital Epidemiology · doi:10.1086/652525 · Cited by 100
Recurrent furunculosis: a review of the literature
Demos, M., McLeod, M. P., & Nouri, K. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.11151.x · Cited by 81
Yang, H., Zhang, Y., Yu, J., Huang, Y., Zhang, X., & Wei, H. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01793-13 · Cited by 79
“aureus (MRSA) (4, 5), are becoming a serious problem worldwide; therefore, there is an urgent need to develop effective therapeutic agents against MRSA (6).”
BackgroundAn update on community-associated MRSA virulence
Kobayashi, S. D., & DeLeo, F. R. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.07.009 · Cited by 92
Lo, C.-W., Lai, Y.-K., Liu, Y.-T., Gallo, R. L., & Huang, C.-M. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.319 · Cited by 76
“It has been documented that skin and soft tissue infections make up most of the cases of MRSA infections (Miller et al., 2005), although community-associated MRSA infections may cause more severe necrotizing pneumonia (Hageman et al.”
Panton-Valentine Leukocidin Genes in Staphylococcus aureus
Melles, D. C., van Leeuwen, W. B., Boelens, H. A. M., Peeters, J. K., Verbrugh, H. A., & van Belkum, A. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1207.050865 · Cited by 59
Shallcross, L. J., Williams, K., Hopkins, S., Aldridge, R. W., Johnson, A. M., & Hayward, A. C. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03153.x · Cited by 78
“Panton–Valentine leukocidin (PVL) containing strains of Staphylococcus aureus have emerged worldwide as an important cause of severe skin and soft tissue infections [1], necrotizing pneumonia and sepsis [2,3].”
BackgroundSnydman, D. R. (2006) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)70362-6 · Cited by 78
Credito, K. L., Lin, G., & Appelbaum, P. C. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01455-06 · Cited by 84
Community-associated methicillin-resistant Staphylococcus aureus immune evasion and virulence
Graves, S. F., Kobayashi, S. D., & DeLeo, F. R. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0573-x · Cited by 76
“Although the vast majority of CA-MRSA infections are of skin and soft tissue, the pathogen has capacity to cause severe invasive disease [14, 15].”
BackgroundLiang, S. Y., & Mackowiak, P. A. (2007) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2007.01.010 · Cited by 82
Hamilton, S. M., Bryant, A. E., Carroll, K. C., Lockary, V. M., Ma, Y., McIndoo, E. R., Miller, L. G., Perdreau‐Remington, F., Pullman, J. R., Risi, G. F., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/523581 · Cited by 83
“Notably, toxic shock syndrome toxin 1 was absent from PVL gene-positive strains [11, 20].”
BackgroundInfluentialSelf-citationO’Hara, F. P., Guex, N., Word, J. M., Miller, L. A., Becker, J. A., Walsh, S. L., Scangarella, N. E., West, J. M., Shawar, R. M., & Amrine‐Madsen, H. (2008) · The Journal of Infectious Diseases · doi:10.1086/524684 · Cited by 75
“Although the association between PVL and serious skin abscesses in humans [11] is at odds with the observation”
BackgroundSelf-citationThappeta, K. R. V., Vikhe, Y. S., Yong, A. M. H., Chan‐Park, M. B. E., & Kline, K. A. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00016 · Cited by 80
Sun, D., Xu, D., Yang, C., Chen, J., Shahzad, M. B., Sun, Z., Zhao, J., Gu, T., Yang, K., & Wang, G. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.07.050 · Cited by 74
Moellering, R. C., Graybill, J. R., McGowan, J. E., & Corey, L. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.04.001 · Cited by 84
Seybold, U., Halvosa, J. S., White, N., Voris, V., Ray, S. M., & Blumberg, H. M. (2008) · PEDIATRICS · doi:10.1542/peds.2007-3161 · Cited by 80
“02 Cocaine, n (%) 9 (9) 5 (9) 4 (9) 0.”
BackgroundAlekshun, M. N., & Levy, S. B. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.12.040 · Cited by 87
“more virulent producing a range of infections in healthy individuals (such as athletes and military personnel) as well as those with underlying disease [23,24].”
BackgroundNecrotizing fasciitis in southeast Taiwan: clinical features, microbiology, and prognosis
Bair, M., Chi, H., Wang, W., Hsiao, Y.-C., Chiang, R.-A., & Chang, K.-Y. (2008) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2008.04.015 · Cited by 74
Tattevin, P., Schwartz, B. S., Graber, C. J., Volinski, J., Bhukhen, A., Bhukhen, A., Mai, T. T., Vo, N. H., Dang, D., Phan, T. H., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis527 · Cited by 78
Self-citationThe changing face of community-acquired methicillin-resistant Staphylococcus aureus
Kale, P. R., & Dhawan, B. (2016) · Indian Journal of Medical Microbiology · doi:10.4103/0255-0857.188313 · Cited by 79
“[14-17] Although much less frequent than infections of the skin, CA-MRSA strains also can cause invasive, rapidly progressive, life-threatening infections, such as necrotising pneumonia,[17] severe sepsis[18] and necrotising fasciitis.[19] Of particular concerns are recent reports about the introduction of highly epid…”
BackgroundPanton-Valentine Leukocidin: A Marker of Severity for Staphylococcus aureus Infection?
Etienne, J. (2005) · Clinical Infectious Diseases · doi:10.1086/432481 · Cited by 73
“Cases of MRSA infection associated with severe necrotizing fasciitis and/or pyomyositis has also been reported recently [15, 16].”
BackgroundCervico‐facial necrotizing fasciitis
Ord, R. A., & Coletti, D. P. (2009) · Oral Diseases · doi:10.1111/j.1601-0825.2008.01496.x · Cited by 70
Napolitano, L. M. (2009) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2009.04.006 · Cited by 78
Surveillance and management of multidrug-resistant microorganisms
Orsi, G. B., Falcone, M., & Venditti, M. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.77 · Cited by 80
Zhang, L., Li, D., Li, X., Hu, L., Cheng, M., Xia, F., Gong, P., Wang, B., Ge, J., Zhang, H., et al. (2016) · Scientific Reports · doi:10.1038/srep29344 · Cited by 70
Tatiya-aphiradee, N., Chatuphonprasert, W., & Jarukamjorn, K. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.142 · Cited by 73
Hermos, C., Yoong, P., & Pier, G. B. (2010) · Clinical Infectious Diseases · doi:10.1086/656742 · Cited by 72
Carey, A. J., Della‐Latta, P., Huard, R. C., Wu, F., Graham, P. L., Carp, D., & Saiman, L. M. (2010) · Infection Control and Hospital Epidemiology · doi:10.1086/652526 · Cited by 72
“Community-associated MRSA (CA-MRSA) genotypes and phenotypes are now emerging as important causes of infection in people without traditional risk factors for MRSA infections.(9,10) Recent reports of vaginal carriage of CA-MRSA in pregnant women(11,12) and patient-to-patient transmission of CA-MRSA resulting in postpar…”
BackgroundA comparison of necrotising fasciitis in diabetics and non-diabetics: a review of 127 patients
Tan, J. H., Koh, B. H. J., Hong, C. C., Lim, S. H., Liang, S., Chan, G. W. H., Wang, W., & Nather, A. (2016) · The Bone & Joint Journal · doi:10.1302/0301-620x.98b11.37526 · Cited by 73
“16,17 Types III and IV are less common and are caused by Vibrio species organisms and fungal infections, respectively.”
BackgroundYoung, L. M., & Price, C. S. (2008) · Surgical Infections · doi:10.1089/sur.2007.052 · Cited by 67
“The first reports of NF caused by CA-MRSA affected a series of patients in Los Angeles, California [3].”
BackgroundResultCommunity associated methicillin-resistant Staphylococcus aureus.
Mertens, R., Seyler, L., Lacor, P., & Denis, O. (2012) · PubMed · doi:10.2143/acb.67.4.2062665 · Cited by 66
Tamarit, A. B., Cháves, F., Rojo, P., & Otero, J. R. (2006) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1157/13083373 · Cited by 74
Phenotypic Prediction Rule for Community-Associated Methicillin-Resistant Staphylococcus aureus
Popovich, K., Hota, B., Rice, T., Aroutcheva, A., & Weinstein, R. A. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00044-07 · Cited by 67
Methicillin-resistant Staphylococcus aureus in HIV-infected patients
Hidrón, A., Moanna, A., Kempker, R. R., & Rimland, D. (2010) · Infection and Drug Resistance · doi:10.2147/idr.s7641 · Cited by 73
“very few case reports, which impedes conclusions on comparative severity and clinical presentations.(87,88) However, in”
Giudice, P. D., Blanc, V., Durupt, F., Bes, M., Martinez, J.-P., Counillon, E., Lina, G., Vandenesch, F., & Étienne, J. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06910.x · Cited by 84
Management of Skin and Soft-Tissue Infections in the Emergency Department
Abrahamian, F. M., Talan, D. A., & Moran, G. J. (2008) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2007.12.001 · Cited by 70
“The spectrum of antibiotic coverage should include gram-positive, gram-negative, and anaerobic organisms, with special attention to resistant organisms (eg, CA-MRSA) [13].”
BackgroundInfluentialStaphylococcus aureus: An Old Pathogen with New Weapons
Tang, Y., & Stratton, C. W. (2010) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2010.01.005 · Cited by 74
Chi, C.-Y., Lin, C.-C., Liao, I.-C., Yao, Y.-C., Shen, F.-C., Liu, C.-C., & Lin, C.-F. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit445 · Cited by 65
“interest in the potential importance of PVL in SSTIs [3].”
BackgroundTreatment approaches for community-acquired methicillin-resistant Staphylococcus aureus infections
Ellis, M. W., & Lewis, J. S. (2005) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000186850.54040.fc · Cited by 70
Antri, K., Rouzic, N., Dauwalder, O., Boubekri, I., Bes, M., Lina, G., Vandenesch, F., Tazir, M., Ramdani‐Bouguessa, N., & Étienne, J. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03273.x · Cited by 66
“These PVL-positive C-MRSA clones are commonly responsible for skin and soft-tissue infections, but can also cause life-threatening infections such as necrotizing pneumonia [3], fasciitis [4], and bone and joint infections [5,6].”
BackgroundStaphylococcus aureus Impairs the Function of and Kills Human Dendritic Cells via the LukAB Toxin
Berends, E. T. M., Zheng, X., Zwack, E. E., Ménager, M. M., Cammer, M., Shopsin, B., & Torres, V. J. (2019) · mBio · doi:10.1128/mbio.01918-18 · Cited by 72
Aragón‐Sánchez, J., Quintana-Marrero, Y., Lázaro‐Martínez, J. L., Hernández-Herrero, M. J., García‐Morales, E., Montesinos, J. V. B., & Cabrera, J. J. (2009) · The International Journal of Lower Extremity Wounds · doi:10.1177/1534734609344106 · Cited by 63
“00 Hospital stay, median days (range) 20 (2-209) 20.”
van Belkum, A. (2006) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000235159.40184.61 · Cited by 71
Necrotizing Soft Tissue Infections
Shiroff, A. M., Herlitz, G. N., & Gracias, V. H. (2012) · Journal of Intensive Care Medicine · doi:10.1177/0885066612463680 · Cited by 64
Methamphetamine Use and Methicillin-Resistant Staphylococcus aureus Skin Infections
Cohen, A. L., Shuler, C., McAllister, S., Fosheim, G. E., Brown, M. G., Abercrombie, D., Anderson, K., McDougal, L. K., Drenzek, C., Arnold, K., et al. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1311.070148 · Cited by 64
“A recent case series of 14 patients with MRSA necrotizing fasciitis found that 43% of the patients had current or past injection drug use (28).”
BackgroundKaiser, J. C., Sen, S., Sinha, A., Wilkinson, B. J., & Heinrichs, D. E. (2016) · Molecular Microbiology · doi:10.1111/mmi.13495 · Cited by 70
“It is capable of infecting nearly everybody site to cause infections that range from mild skin and soft tissue infections to life-threatening pneumonia, necrotizing fasciitis and sepsis (Gillet et al., 2002; Gonzalez et al., 2005; Miller et al., 2005; King et al., 2006).”
BackgroundCampoccia, D., Baldassarri, L., Pirini, V., Ravaioli, S., Montanaro, L., & Arciola, C. R. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.07.006 · Cited by 63
“A recent investigation showed as in a series of 14 cases of necrotizing fasciitis caused by CA-MRSA, the lukE/ lukD genes were always present in all isolates in association with the PVL toxin [21].”
Leiblein, M., Wagner, N., Adam, E., Frank, J. M., Marzi, İ., & Nau, C. (2020) · Orthopaedic Surgery · doi:10.1111/os.12804 · Cited by 68
Monecke, S., Slickers, P., Hotzel, H., Richter‐Huhn, G., Pohle, M., Weber, S., Witte, W., & Ehricht, R. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01420.x · Cited by 61
Tsai, Y.-H., Huang, K., Shen, S.-H., Hsu, W., Peng, K., & Huang, T. (2011) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2011.11.001 · Cited by 60
“Wound location, n (n died) Upper extremity 21 (4) 19 (2) Lower extremity 37 (5) 41 (10) First operation, n (n died) Fasciotomy 58 (9) 57 (11) Amputation 0 (0) 3 (1) Final operation after first”
Kaplan, S. L. (2005) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2005.05.011 · Cited by 60
“Necrotizing fasciitis caused by CA-MRSA has been described in adults, many of whom have chronic underlying illnesses [ 19 ].”
BackgroundModelling an outbreak of an emerging pathogen
Kajita, E., Okano, J. T., Bodine, E. N., Layne, S. P., & Blower, S. M. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1660 · Cited by 66
“Whereas HA-MRSA strains cause morbidity and mortality primarily in hospitalized patients, infection with CA-MRSA strains has caused the deaths of otherwise healthy individual”
BackgroundJappe, U., Heuck, D., Strommenger, B., Wendt, C., Werner, G., Altmann, D., & Witte, W. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.133 · Cited by 68
“Some are primarily fatal owing to necrotizing pneumonia (Lina et al., 1999; Gillet et al., 2002) and necrotizing fasciitis (Miller et al., 2005) for both adults and children (Fridkin et al., 2005).”
BackgroundInfluentialPozzi, C., Wilk, K., Lee, J. C., Gening, M. L., Nifantiev, N. E., & Pier, G. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046648 · Cited by 63
“aureus isolates used were CP8 strain MN8 [23], CP5 strain Newman [24], and nontypable (NT) USA 300 MRSA strain LAC [25].”
BackgroundKilic, A., Li, H., Stratton, C. W., & Tang, Y.-W. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.01546-06 · Cited by 61
“The CA-MRSA clone in the United States has resulted in several pediatric deaths (16, 23 , 25), suggesting that children may have an increased risk of serious MRSA infections compared to adults.”
BackgroundO’brien-simpson, N. M., Pantarat, N., Attard, T. J., Walsh, K. A., & Reynolds, E. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151694 · Cited by 68
“It is now recognised that the rates and severity of infections caused by antibiotic and multi-drug resistant bacteria are increasing year by year and are becoming harder and more complicated to treat and manage [1, 2].”
BackgroundSchilcher, K., Andreoni, F., Uchiyama, S., Ogawa, T., Schuepbach, R. A., & Zinkernagel, A. S. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu091 · Cited by 64
“necrotizing fasciitis, and pneumonia [1–3].”
Epidemiology and risk factors for Staphylococcus aureuscolonization in children in the post-PCV7 era
Lee, G. M., Huang, S. S., Rifas‐Shiman, S. L., Hinrichsen, V. L., Pelton, S. I., Kleinman, K., Hanage, W. P., Lipsitch, M., McAdam, A. J., & Finkelstein, J. A. (2009) · BMC Infectious Diseases · doi:10.1186/1471-2334-9-110 · Cited by 67
“[4-12] Treatment of these infections has become more difficult in recent years due to the emergence and rapid spread of drug-resistant strains such as methicillin-resistant S.”
Asghar, A. H. (2014) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.304.4946 · Cited by 76
Sun, D., Xu, D., Yang, C., Shahzad, M. B., Sun, Z., Xia, J., Zhao, J., Gu, T., Yang, K., & Wang, G. (2016) · Scientific Reports · doi:10.1038/srep29244 · Cited by 62
Harro, C., Betts, R., Orenstein, W., Kwak, E.-J., Greenberg, H. E., Onorato, M. T., Hartzel, J., Lipka, J., DiNubile, M. J., & Kartsonis, N. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00356-10 · Cited by 57
Bode, L. G. M., Wertheim, H. F. L., Kluytmans, J. A. J. W., Bogaers‐Hofman, D., Vandenbroucke‐Grauls, C. M. J. E., Roosendaal, R., Troelstra, A., Box, A. T. A., Voss, A., van Belkum, A., et al. (2011) · Journal of Hospital Infection · doi:10.1016/j.jhin.2011.05.009 · Cited by 57
Rudkjøbing, V. B., Thomsen, T. R., Xu, Y., Kreft, R., Ahmed, A., Eickhardt, S. R., Bjarnsholt, T., Poulsen, S. S., Nielsen, P. H., Earl, J. P., et al. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1976-2 · Cited by 62
“pyogenes and Clostridium perfringens need different treatment modalities [2, 18, 19] than, for example, methicillinresistant Staphylococcus aureus [20], or Streptococcus pneumoniae [21].”
BackgroundAntibiotic resistance in Staphylococcus aureus and its relevance in therapy
Bal, A. M., & Gould, I. M. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.13.2257 · Cited by 61
Abdelgalil, M. H., Ammar, Y. A., Ali, G. A. M. E., Ali, A. K., & Ragab, A. (2022) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2022.134443 · Cited by 56
Laboratory Diagnosis of Bone, Joint, Soft-Tissue, and Skin Infections
Wilson, M. L., & Winn, W. C. (2008) · Clinical Infectious Diseases · doi:10.1086/525535 · Cited by 56
Vidlak, D., & Kielian, T. (2016) · Infection and Immunity · doi:10.1128/iai.00117-16 · Cited by 57
“aureus USA300 LAC, which was originally isolated from a patient with a skin and soft tissue infection (16, 21), was cured of two antibiotic resistance plasmids and designated USA300 LAC-13C (referred to as LAC in the present study) as previously described (41).”
BackgroundRecurrent furunculosis – challenges and management: a review
Ibler, K. S., & Kromann, C. B. (2014) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s35302 · Cited by 72
“26”
Shumba, P., Shambat, S. M., & Siemens, N. (2019) · Toxins · doi:10.3390/toxins11060332 · Cited by 62
“Specifically CA-MRSA clones are associated with highly aggressive infections, including NSTIs, in otherwise healthy individuals [11].”
BackgroundInfluentialLo, W., Wang, C., Lin, W.-J., Wang, S.-R., Teng, C., Huang, C., & Chen, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015791 · Cited by 59
“Reports of rapidly progressive fatal disease and serious complications resulting from virulent CA-MRSA infection including sepsis, necrotizing pneumonia, and necrotizing fasciitis have alerted medical professionals and the community alike to the need to face the increasing threat from community-based MRSA infections […”
BackgroundArsic, B., Zhu, Y. L., Heinrichs, D. E., & Mcgavin, M. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045952 · Cited by 64
“USA300 LAC Hypervirulent pandemic CA-MRSA Los Angeles county clone, clonal complex CC8 spa t008 [77,78] Barry Kreiswirth”
BackgroundAmato, M. M., Pershing, S., Walvick, M. D., & Tanaka, S. C. (2013) · Journal of American Association for Pediatric Ophthalmology and Strabismus · doi:10.1016/j.jaapos.2012.12.151 · Cited by 59
Robinson, J. O., Pearson, J. C., Christiansen, K., Coombs, G. W., & Murray, R. J. (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-008-0632-1 · Cited by 60
“necrotising pneumonitis and necrotising fasciitis) have also been described [ 7 , 8]. Bacteraemia and endocarditis due to cMRSA clones have been reported, but the epidemiology of these more severe infections is incompletely understood [9– 12].”
BackgroundMarine Bacteria as a Leading Cause of Necrotizing Fasciitis in Coastal Areas of South Korea
Park, K., Jung, S., Jung, Y.-S., Shin, J.-H., & Hwang, J. (2009) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2009.80.646 · Cited by 54
“2) Two extremities 11 (5) Three extremities 2 (0.”
BackgroundParta, M., Goebel, M. C., Matloobi, M., Stager, C. E., & Musher, D. M. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00351-09 · Cited by 54
Community-associated Methicillin-resistant Staphylococcus aureus: Overview and Local Situation
Wijaya, L., Hsu, L. Y., & Kurup, A. (2006) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v35n7p479 · Cited by 61
Stenstrom, R., Grafstein, E., Romney, M., Fahimi, J., Harris, D., Hunte, G., Innes, G., & Christenson, J. (2009) · CJEM · doi:10.1017/s1481803500011623 · Cited by 53
Hospitalist Perspective on the Treatment of Skin and Soft Tissue Infections
Amin, A., Cerceo, E. A., Deitelzweig, S. B., Pile, J. C., Rosenberg, D. J., & Sherman, B. M. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.04.018 · Cited by 59
“The NSTIs that are monomicrobial can be caused by Streptococcus pyogenes, Vibrio vulnificus, Aeromonas hydrophilia, anaerobic streptococci, or, occasionally, community-acquired MRSA (CAMRSA).(14,32) Surgical site infections are usually caused by S aureus and streptococcal species, but those that involve colonic, vagin…”
BackgroundJankauskaitL·, V., VitkauskienL·, A., Lazauskas, A., Baltrušaitis, J., ProsyL·evas, I., & AndruleviL·ius, M. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.06.121 · Cited by 52
Comparison of Necrotizing Fasciitis and Sepsis Caused by Vibrio vulnificus and Staphylococcus aureus
Tsai, Y.-H., Wen-Wei Hsu, R., Huang, K.-C., & Huang, T.-J. (2011) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.i.01679 · Cited by 52
“Hepatic dysfunction alone 20 (6) 8 (0) Diabetes mellitus alone 7 (1) 24 (5) Diabetes mellitus with gout or steroid intake 4 2”
BackgroundPotential of Mobile Phones to Serve as a Reservoir in Spread of Nosocomial PathogensPreprint
Bhat, S. S., Sundeep Hegde, K., & Salian, S. (2011) · CogPrints (University of Southampton) · Cited by 52
Lessa, F. C., Mu, Y., Ray, S. M., Dumyati, G. K., Bulens, S. N., Gorwitz, R. J., Fosheim, G. E., DeVries, A., Schaffner, W., Nadle, J., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis408 · Cited by 54
“Poor outcomes associated with MRSA USA300 infections have been reported [11–16].”
BackgroundMoussa, I. M., & Shibl, A. M. (2009) · Saudi Medical Journal · doi:10.15537/1658-3175.4711 · Cited by 60
Antibiotics in Necrotizing Soft Tissue Infections
Urbina, T., Razazi, K., Ourghanlian, C., Woerther, P., Chosidow, O., Lepeule, R., & de Prost, N. (2021) · Antibiotics · doi:10.3390/antibiotics10091104 · Cited by 57
“aureus carrying the Panton-Valentine leucocidin was reported in the United States [22,23].”
BackgroundSkin and Soft Tissue Infections
Mistry, R. D. (2013) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2013.06.011 · Cited by 54
“Skin and soft tissue infections (SSTIs) encompass a wide range of severity, from impetigo to fulminant “flesh-eating” invasive infection, better known as necrotizing fasciitis.(4) However, the predominant skin infections encountered by pediatric practitioners include cutaneous abscesses and cellulitis.”
BackgroundNecrotizing Soft Tissue Infections
Hussein, Q. A., & Anaya, D. A. (2013) · Critical Care Clinics · doi:10.1016/j.ccc.2013.06.001 · Cited by 50
“In more recent reports, MRSA soft tissue infections seem to have gained an important role as causative organisms of community-acquired NSTI.(26) Although antimicrobial therapy is an essential adjunctive therapy, the principles of treatment for any kind of surgical infection apply in particular to NSTI: source control,…”
BackgroundInfluentialEllis, M. W., Griffith, M. E., Jorgensen, J. H., Hospenthal, D. R., Mende, K., & Patterson, J. E. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.02352-08 · Cited by 50
“Diseases caused by CA-MRSA range from cutaneous infection to life-threatening systemic illness (13, 14, 28 , 31); however, the majority of disease manifests as suppurative skin and soft-tissue infections (SSTI) (13, 14, 28, 31, 32).”
BackgroundInfluentialPatel, M. (2009) · Drugs · doi:10.2165/00003495-200969060-00004 · Cited by 58
“In a retrospective review of MRSA wound cultures at an urban hospital in Los Angeles, CA, USA, 14 of 843 patients from the community were found to have necrotizing fasciitis, necrotizing myositis or both.([70]) All of the MRSA isolates were susceptible to clindamycin, cotrimoxazole and rifampin.”
BackgroundKim, M., Oh, G., Jang, Y., Ko, S., Park, W.-S., Choi, I., Kim, Y., & Jung, W. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.110352 · Cited by 53
Chi Thuong, T., Dac Tho, N., Thi Hoa, N., Minh Phuong, N. T., Van Tuan, L., Song Diep, T., Lindsay, J., The Dung, N., Van Cam, B., Quoc Thinh, L., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000822 · Cited by 48
“aureus (MRSA) are widespread in hospitals, community-acquired MRSA (CA-MRSA) is increasingly responsible for severe skin and soft tissue infections, necrotising fasciitis, and a fatal form of necrotising pneumonia, in previously healthy individuals [3–5].”
BackgroundWeese, J. S., Faires, M. C., Rousseau, J. D., Bersenas, A. M. E., & Mathews, K. A. (2007) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.231.9.1361 · Cited by 56
Necrotizing Fasciitis: Manifestations, Microbiology and Connection with Black Tar Heroin*
Dunbar, N. M., & Harruff, R. C. (2007) · Journal of Forensic Sciences · doi:10.1111/j.1556-4029.2007.00452.x · Cited by 50
“Staphylococcus aureus represents another potentially virulent organism that has been reported in necrotizing fasciitis due to needle punctures (12) and injection drug use (13).”
BackgroundSpread of methicillin‐resistant Staphylococcus aureus USA300 in a neonatal intensive care unit
McAdams, R. M., Ellis, M. W., Trevino, S., & Rajnik, M. (2008) · Pediatrics International · doi:10.1111/j.1442-200x.2008.02646.x · Cited by 60
Skin and Soft Tissue Infections
Lopez, F. A., & Lartchenko, S. (2006) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2006.09.006 · Cited by 54
Sifri, C. D., Park, J., Helm, G. A., Stemper, M. E., & Shukla, S. K. (2007) · Clinical Infectious Diseases · doi:10.1086/522171 · Cited by 52
Zeledon, J. I., McKelvey, R. L., Servilla, K. S., Hofinger, D. M., Konstantinov, K. N., Kellie, S., Sun, Y., Massie, L. W., Hartshorne, M. F., & Tzamaloukas, A. H. (2008) · International Urology and Nephrology · doi:10.1007/s11255-007-9323-6 · Cited by 48
“The exponential increase in community-acquired MRSA infections nationally, largely involving skin and soft tissue and due to a single clone of MRSA [25, 26 ], raised our concern that these cases could be a manifestation of this genotype, but this was not the case.”
BackgroundLooking toward basic science for potential drug discovery targets against community‐associated MRSA
Otto, M. J. (2009) · Medicinal Research Reviews · doi:10.1002/med.20160 · Cited by 54
Metadata
- Authors
- Miller, L. G., Perdreau-Remington, F., Rieg, G., Mehdi, S., Perlroth, J., Bayer, A. S., Tang, A. W., Phung, T. O., & Spellberg, B.
- Affiliations
- University of California, Los Angeles (US)
- St. Mary Medical Center (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-04-07
- Volume
- 352
- Issue
- 14
- Pages
- 1445-1453
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2150907717
- Cited by
- 1,053
- References
- 62
- Citations by year
- 2026: 11 · 2025: 14 · 2024: 17 · 2023: 20 · 2022: 31 · 2021: 16 · 2020: 34 · 2019: 28 · 2018: 16 · 2017: 26 · 2016: 39 · 2015: 44 · 2014: 47 · 2013: 44 · 2012: 65
- FWCI
- 72.09
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention (R01/CCR923417-01)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Health Sciences › Medicine › Infectious Diseases › Otolaryngology and Infectious Diseases
- Keywords
- necrotizing fasciitis, community-associated methicillin-resistant Staphylococcus aureus, necrotizing myositis, intravenous drug use, ST8, USA300, Panton-Valentine leukocidin, empirical antibiotic therapy, Los Angeles
- MeSH terms
- Adult, Aged, DNA, Bacterial, Female, Genes, Bacterial, Genotype, Humans, Male, Microbial Sensitivity Tests, Middle Aged, Risk Factors, Staphylococcal Infections, Staphylococcus aureus, Bacterial Typing Techniques, Methicillin Resistance, Bacteremia, Community-Acquired Infections, Fasciitis, Necrotizing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.